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Ceramides are the major component of the stratum
corneum, accounting for 30%±40% of stratum cor-
neum lipids by weight, and are composed of at least
seven molecular groups (designated ceramides 1±7).
Stratum corneum ceramides, together with choles-
terol and fatty acids, form extracellular lamellae that
are responsible for the epidermal permeability bar-
rier. Previous studies indicated that b-glucocerebro-
sidase- and sphingomyelinase-dependent ceramide
production from glucosylceramides and sphingo-
myelins, respectively, is important for epidermal
permeability barrier homeostasis. A recent study
indicated that sphingomyelins are precursors of two
stratum corneum ceramide molecular groups (cer-
amides 2 and 5). In this study, we have examined the
role of glucosylceramides in the generation of each
of the seven stratum corneum ceramide molecular
groups. First, the structures of various glucosylcer-
amide species in human epidermis were determined
by gas chromatography±mass spectrometry, fast
atom bombardment±mass spectrometry, and nuclear
magnetic resonance. The results indicate that total
epidermal glucosylceramides are composed of six
distinct molecular groups, glucosylceramides 1±6.
Glucosylceramide 1 contains sphingenine and non-
hydroxy fatty acids, glucosylceramide 2, phytosphin-
gosine and nonhydroxy fatty acids, glucosylceramide
3, phytosphingosine with one double bond and non-
hydroxy fatty acids, glucosylceramide 4, sphingenine
and a-hydroxy fatty acids, glucosylceramide 5,
phytosphingosine and a-hydroxy fatty acids, and
glucosylceramide 6, phytosphingosine with one
double bond and a-hydroxy fatty acids. The non-
hydroxy fatty acids typically have 16±24-carbon-
length chains, whereas a-hydroxy fatty acids are
limited to 24-, 25-, and 26-carbon chains. The sphin-
gosine bases are C18 or C20 chains. Next, acylgluco-
sylceramides and glucosylceramides were treated
with b-glucocerebrosidase and the ceramides released
were compared with stratum corneum ceramides.
Ceramide moieties of acylglucosylceramides and
glucosylceramides 1, 2, 4±6 correspond to stratum
corneum ceramides 1±7. These results, together with
those of our previous reports characterizing epider-
mal sphingomyelins, indicate that all ceramide
species, including w-hydroxy fatty-acid-containing
ceramides, are derived from glucosylceramides, and
fractions of ceramides 2 and 5 are from sphingo-
myelins. Furthermore, structural analysis of gluco-
sylceramides revealed that human epidermal
glycosphingolipids display a unique lipid pro®le that
is rich in very long chain hydroxylated (a- and
w-hydroxy) fatty acids and phytosphingosine.
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G
lucosylceramide (GlcCer) is a simple glycosphingo-
lipid (GSL) composed of one mole each of glucose
and ceramide (Cer). Cer is composed of a sphingo-
sine base and an amide-linked fatty acid (FA). GlcCer
is distributed widely in mammalian tissues and is the
major precursor for more complex GSLs. In the epidermis,
however, GlcCers were reported to be the only GSL (Gray and
Yardley, 1975), until unique acylated GlcCers (acylglucosylcer-
amides, acylGlcCers) were found later in pig and human epidermis
(Gray et al, 1978). The structures of GlcCers in pig and fetal rat
epidermis (Wertz and Downing, 1983b; Wertz et al, 1984) and
cultured human keratinocytes, as well as acylGlcCers in human
(Hamanaka et al, 1989, 1990, 1993), pig (Wertz and Downing
1983a; Abraham et al, 1985; Bowser et al, 1985), and guinea pig
(Uchida et al, 1988), have been determined, but the structures of
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GlcCers in vivo in human epidermis have not yet been completed.
These prior studies indicate that the epidermal GlcCers display
molecular heterogeneity. In particular, acylGlcCers, i.e., the w-OH
GlcCer carrying an ester-linked FA, have been reported only in the
epidermis and not in other tissues, including the dermis. We found
that acylGlcCers isolated from human epidermis predominantly
carry linoleic acid as their ester-linked FA (Hamanaka et al, 1989),
whereas pig (Wertz and Downing, 1983a; Bowser et al, 1985),
guinea pig (Uchida et al, 1988), and cultured human keratinocytes
(Hamanaka et al, 1990, 1993) contain other FAs, as well as linoleic
acid. We have named epidermis-speci®c, linoleic-acid-containing
w-OH GlcCers as epidermosides (Fig 1) (Hamanaka et al, 1989),
because these essential-fatty-acid-containing lipids are involved in
the physiologic maintenance of the epidermal permeability barrier
(Hansen, 1986). GlcCer and acylGlcCer expression (Ponec et al,
1988), GlcCer synthase activity (Sando et al, 1996; Chujor et al,
1998; Watanabe et al, 1998), and GlcCer structural heterogeneity
(Ponec et al, 1988) increase with keratinocyte differentiation.
GlcCers and acylGlcCers are thought to be located primarily in
lamellar bodies (Wertz and Downing, 1982). The lamellar body
membrane fuses with the plasma membrane on the apical surface of
granular cells, at which point its contents are extruded into the
interface between the stratum granulosum and the stratum
corneum (SC) (Elias and Menon, 1991). Coincident with the
stratum granulosum±SC transition, the glucose moiety of
acylGlcCers and GlcCers is hydrolyzed by b-glucocerebrosidase
(b-GlcCer'ase), resulting in the production of Cers in the SC
(Holleran et al, 1993; 1994). Cers play a critical role in the
formation of the permeability barrier, together with cholesterol and
FAs in the SC.
SC Cers are composed of at least seven molecular groups (Wertz
and Downing, 1983a; Robson et al, 1994; Vietzke et al, 1999;
2001). De®ciency of b-GlcCer'ase or inhibition of its activity in the
epidermis decreases the amount of SC Cers and creates an
incompetent epidermal permeability barrier (Holleran et al, 1993,
1994), suggesting that enzymatic hydrolysis of GlcCer is required
for epidermal barrier formation. Sphingomyelinase-mediated
hydrolysis of sphingomyelin (SM) is also involved in epidermal
permeability barrier homeostasis (Jensen et al, 1999; Schmuth et al,
2000). These prior studies indicate that both GlcCers and SMs are
important precursors for SC Cers. Furthermore, previous studies
demonstrated that not only the total amount of SC Cers but also
the distribution of each Cer molecular species is important for the
formation of lamellar bilayer structures in the SC (Bouwstra et al,
1998). Indeed, alteration of Cer composition has been reported in
several skin diseases that display epidermal barrier abnormalities
(Imokawa et al, 1991; Motta et al, 1993; Paige et al, 1994; Bleck et
al, 1999; Schreiner et al, 2000). Little is known, however, about the
mechanism that is responsible for these alterations. Thus,
characterization of the speci®c synthetic pathways for each Cer
species is important to elucidate the regulation of SC Cer synthesis.
Recently, we analyzed the structures of epidermal SMs and
demonstrated that SC Cer 2 and 5 were derived in part from these
precursors (Uchida et al, 2000). The role of GlcCers in SC Cer
generation has not been explored, however.
The esteri®ed, but not the nonesteri®ed, form of w-OH Cer
(acylCer; Cer 1) has been observed in human and pig SC, where it
is an important component of the extracellular lamellar bilayer
structures (Wertz and Downing, 1985; Robson et al, 1994;
Bouwstra et al, 1998). In addition, w-OH Cer is covalently
bound to corneocyte envelope proteins and forms the corneocyte
lipid envelope (CLE) (Wertz and Downing, 1987; Wertz et al,
1989; Marekov and Steinert, 1998; Doering et al, 1999a; Elias et al,
2000). The CLE has been suggested to be a scaffold upon which
extracellular lamellar bilayer structures form in the SC (Downing,
1992). Previous studies indicated that w-OH GlcCers (GlcCer with
nonesteri®ed w-OH FA) are found in pig and fetal rat epidermis
(Gray and White, 1978; Wertz and Downing, 1983b; Wertz et al,
1984; Hamanaka et al, 1988). We could not detect w-OH GlcCers
in human cultured keratinocytes, however (Hamanaka et al, 1993).
Two explanations are possible; ®rst, the absence of w-OH GlcCers
may be due simply to culture conditions; second, this putative
intermediate may not be detectable in vivo in human epidermis.
Neither of these possibilities has been examined adequately, as
w-OH GlcCers in human epidermis have not been characterized.
In this study, we have examined the structure of normal human
epidermal GlcCers in order to clarify the role of GlcCers as a
potential precursor of speci®c SC Cer moieties. In addition to
acylGlcCers described previously (Hamanaka et al, 1989), six
groups of GlcCers were identi®ed. This variation is due to the
combination of different sphingosine bases and amide-linked FAs.
We did not detect the presence of GlcCer with free w-OH FAs,
however (w-OH GlcCers). Finally, a comparison between Cers
generated from acylGlcCers and GlcCers by b-GlcCer'ase with
Cers isolated directly from the SC revealed that the GlcCers are
direct precursors of SC Cer 1±7.
MATERIALS AND METHODS
Materials GlcCers from the spleen of a patient with Gaucher disease
were kindly provided by Dr. M. Oshima (Tohoku University of
Community and Science, Yamagata, Japan) to be used as a standard.
Other sphingolipids were purchased from Sigma (St. Louis, MO).
Human recombinant b-GlcCer'ase was purchased from Genzyme
(Cambridge, MA). Human skin was obtained from amputated tissue
from Japanese patients, 17±86 y old, with no prior history of skin
disorders under the condition of informed consent. Amputation was
performed within 2±3 h after the accidents. No skin abnormalities were
observed in the skin samples. Split-thickness samples of cutaneous sheets
Figure 1. Structure of epidermoside I. Epidermoside I is composed of glucose, a sphingosine base, an amide-linked w-hydroxy FA, and an ester-
linked FA (linoleic acid). d20:1 denotes a 20-carbon dihydroxysphingosine with one double bond. C30 w-h:0 denotes a 30-carbon w-hydroxy fatty
acid without a double bond.
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were prepared using a free hand dermatome (Keisei Medical Industrial,
Tokyo, Japan). The epidermal sheets were obtained by incubation in a
phosphate-buffered saline solution with 0.1% trypsin, pH 7.2, at 37°C
for 1 h.
Thin-layer chromatography (TLC) TLC was performed on silica-
gel 60 high-performance TLC plates (Merck, Darmstadt). GlcCers were
separated with chloroform/methanol/water (40:12:1 vol/vol/vol). The
solvent system for the separation of Cers was as previously described
(Ponec and Weerheim, 1990; Uchida et al, 2000): chloroform to
1.5 cm; chloroform/methanol/acetone (76:16:8 vol/vol/vol) to 1.0 cm;
chloroform/methanol/hexylacetate/acetone (86:4:1:10 vol/vol/vol) to
7.0 cm; chloroform/methanol/acetone (76:20:4 vol/vol/vol) to 2.0 cm;
chloroform/methanol/diethyl ether/ethylacetate/hexylacetate/acetone
(72:4:4:1:4:16 vol/vol/vol) to 7.5 cm; and n-hexane/diethyl ether/acetic
acid (65:35:1 vol/vol/vol) to the top of the plate. GlcCer species were
visualized by spraying with orcinol reagent, following by heating of the
plates at 110°C for 15 min. Cer species were visualized after spraying
with cupric acetate±phosphoric acid, and heating to 160°C for 15 min.
Extraction and isolation of GlcCers Lipids were extracted and GSLs
were puri®ed by DEAE-Toyopearl (Tosoh, Tokyo, Japan) and Unisil
(Clarkson Chemical, Williamsport, Sweden) column chromatography, as
described previously (Hamanaka et al, 1989). The GlcCer species were
obtained in the chloroform/methanol (9:1 vol/vol) fraction following
Unisil column chromatography. This fraction was further separated by
high-performance liquid chromatography (HPLC) using a silica gel
column (Aquasil Senshu Pack 4301-N; 10 mm i.d. 3 30 cm, Senshu
Scienti®c, Tokyo, Japan) using the following programmed gradient
elution: chloroform for the ®rst 60 min, a linear gradient of 0%±20%
methanol in chloroform for the next 120 min, and 20% methanol in
chloroform for the last 60 min, at a ¯ow rate of 1.5 ml per min. The
eluted GlcCer samples were monitored by TLC. This HPLC step
allowed for the separation of four GlcCer fractions.
Gas±liquid chromatographic analysis The GlcCer fractions were
subjected to methanolysis and the resulting FA methylesters were
silylated as trimethylsilylated derivatives as described previously (Karlsson
and Martensson, 1968; Uchida et al, 2000). The sphingosine bases were
also prepared by the methods of Ando and Yu and were converted to
their corresponding trimethylsilylated derivatives (Ando and Yu, 1979).
The derivatives of both FA methylesters and sphingosine bases were then
analyzed by gas±liquid chromatography. Peaks were detected by ¯ame
ionization detector and identi®ed by mass spectrometry (HP 5972;
Hewlett Packard, Palo Alto, CA) on a 0.32 mm i.d. 3 30 m DB-1
capillary column (J & W Scienti®c, Folsom, CA), constant helium ¯ow
pressure 10.5 psi. The electron energy was 70 eV, the ionizing current
was 60 mA, and the accelerator voltage was 3.5 kV (HP 5972 series Mass
Selective Detector). For FA analyses, samples were held at an initial
temperature of 100°C for 5 min, after which the temperature was
increased to 300°C at a rate of 5°C per min; for the sphingosine bases,
the initial temperature was 180°C and it was increased to 230°C at the
same rate.
Negative ion fast atom bombardment±mass spectrometry The
four GlcCer fractions were analyzed with a JEOL HX-110 mass spectro-
meter (JEOL, Tokyo, Japan) in a liquid matrix of triethylenetetramine/
m-nitrobenzylalcohol (1:1 vol/vol). The accelerating voltage was 8 kV
and the primary beam for bombardment was 6 kV XeO.
1H nuclear magentic resonance (NMR) spectroscopy The isolated
GlcCer samples were analyzed in 0.4 ml of chloroform-d1/methanol-d4
(8:2 vol/vol), with a JEOL JNM-GX 500 1H 500 MHz NMR
spectrometer at 40°C. Tetramethylsilane was used as an internal chemical
shift standard.
Beta-GlcCer'ase treatment The four GlcCer fractions, and an
epidermoside I- and II-enriched fraction previously isolated from human
epidermis (Hamanaka et al, 1989), were treated with human recombinant
b-GlcCer'ase. Brie¯y, samples were suspended in a citrate±phosphate
buffer (pH 5.6) containing 5 mM sodium taurocholate and incubated
with b-GlcCer'ase (80 U per ml) at 37°C for 1 h. Cers produced by this
treatment were extracted from the lower phase of Folch's partition
(Folch et al, 1957).
RESULTS
Human epidermal GlcCers GlcCers extracted from human
epidermis gave four bands showing speci®c color reactions to
glycolipids upon orcinol treatment (Fig 2, lane 2). The two GlcCer
bands with the highest Rf values represented epidermosides I and
II. The structure of epidermoside I is shown in Fig 1. The other
two GlcCer bands with lower Rf values were further separated into
four fractions, Fr-1 to Fr-4, by HPLC (Fig 2, lanes 3±6). The
relative amounts of each fraction, as determined by TLC
densitometry, were as follows: Fr-1, 25.3%; Fr-2, 14.0%; Fr-3,
26.0%; and Fr-4, 34.7%.
Structural characterization of human epidermal GlcCers
1H-NMR analysis indicated the presence of the glucose residue
protons including the anomeric proton of b-glucoside as well as the
protons of methyl, methylene, and amide linkage in Cer moieties in
all GlcCer fractions (Table I).
FA compositions analyzed by gas chromatography±mass spectro-
metry are shown in Table II. Major components include saturated
normal FAs in Fr-1 (primarily C24±C28), long chain a-OH FAs
(C26) in Fr-2, a mixture of saturated normal FAs (primarily C24±
C28) and long chain a-OH FAs (C24 and C26) in Fr-3, and long
chain a-OH FAs (C24±C26) in Fr-4. In addition to the major FA
species described above, all fractions contained a minor FA
population composed of saturated nonhydroxy FAs from C16 to
C18, but not C20±C22. As for the sphingosine bases, Fr-1
contained 18-phytosphingosine (t18:0), 18- and 20-phytosphingo-
sine with one double bond (t18:1 and t20:1), and sphingenines
(d18:1 and d20:1); Fr-2 and Fr-3 were composed of 18- and 20-
sphingenine (d18:1 and d20:1); and Fr-4 contained 18- and 20-
phytosphingosine (t18:0 and t20:0), phytosphingosines with one
double bond (t18:1 and t20:1), and sphingenine (d18:1).
The major GlcCer species of each fraction was analyzed by fast
atom bombardment±mass spectrometry (Fig 3) and their structures
were characterized by the detection of pseudo-molecular ions. The
characterized structures are as follows: Glc-C28:0-t20:1, giving an
m/z-value of 910, Glc-C26:0-t20:1 and/or Glc-C28:0-t18:1 for
m/z 882, and Glc-C24:0-t18:0 for m/z 828 (Fig 3A) in Fr-1; Glc-
C26 a h:0-d20:1 for m/z 882 and Glc-C26 a h:0-d18:1 for m/z
854 (Fig 3B) in Fr-2; Glc-C24 a h:0-d20:1 and/or Glc-C26
a h:0-d18:1 for m/z 854 and Glc-C24 a h:0-d18:1 for m/z 826
(Fig 3C) in Fr-3; and Glc-C26 a h:0-t20:1 for m/z 898, Glc-C24
a h:0-t20:1 for m/z 870, and Glc-C24 a h:0-t18:0 for m/z 844
(Fig 3D) in Fr-4. Ions representing fragment species produced
from GlcCer molecules after the elimination of hexose (glucose in
this case) are as follows: m/z 748 from 910, 720 from 882, and 666
from 828 in Fr-1 (Fig 3A); m/z 720 from 882 and 692 from 854 in
Fr-2 (Fig 3B); m/z 692 from 854 and 664 from 826 in Fr-3
(Fig 3C); and m/z 736 from 898, 708 from 870, and 682 from 844
in Fr-4 (Fig 3D). Matrix adduct ions detected in these mass
spectra, as indicated by italic ®gures in Fig 3, are as follows: m/z
1064, 1036, and 982, which are 144 adducts to m/z 910, 882, and
Figure 2. Thin layer chromatogram of human epidermal
GlcCers. Lanes 1 and 2 contain GlcCers as a reference and a human
epidermal glycolipid extract, respectively. Lanes 2±6 show glycolipid
fractions isolated by HPLC; lane 3, Fr-1; lane 4, Fr-2; lane 5, Fr-3; lane 6,
Fr-4.
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828, respectively, in Fr-1 (Fig 3A); m/z 1036 and 1008, adducts to
882 and 854, respectively, in Fr-2 (Fig 3B); m/z 1008 and 980
from 854 and 826, respectively, in Fr-3 (Fig 3C); and m/z 1052,
1024, and 998 from 898, 870, and 844, respectively, in Fr-4
(Fig 3D). Based on these results, human epidermal GlcCers were
classi®ed into six molecular groups (GlcCer-1 to GlcCer-6)
(Table III).
Cers produced by b-GlcCer'ase treatment Figure 4 shows
Cers derived from recombinant human b-GlcCer'ase treatment of
an enriched epidermoside sample. The derivative of epidermoside
I, Glc-[C(26±34) w-h-C18:2]-d18:1/20:1, as shown in lane 3 of
Fig 4, displayed the same mobility as SC Cer 1 in lane 8. The
epidermoside II derivative, Glc-[C(26±34) w-h-C18:2]-t18:1/20:1,
indicated by an arrow in lane 5, corresponded to SC Cer 4 in lane 8.
AcylCer obtained by b-GlcCer'ase treatment from epidermoside II
was then subjected to mild alkaline treatment, yielding a product
(lane 6) migrating between Cer 5 and Cer 6 in lane 8. This ®nding
suggests that the alkaline treatment released linoleic acid by
breaking the ester bond between the w-OH amide-linked FAs
and ester-linked FAs.
All GlcCer fractions, Fr-1 to Fr-4, were treated with b-
GlcCer'ase (Fig 5). The comparison of the derived Cer species
with those endogenous to the SC revealed that the constituents of
Fr-1 exhibited similar mobility to Cer 2, 3, and 4 (lane 3), those of
Fr-2 to Cer 3, 4, and 5 with Cer 2 as a minor component (lane 4),
those of Fr-3 to Cer 4 and 5 with Cer 2 and 3 as minor components
(lane 5), and those of Fr-4 to Cer 6 and 7 with Cer 2, 4, and 5 as
minor components (lanes 6, 7).
DISCUSSION
Much attention has been paid to two characteristics of epidermal
sphingolipids. First, they are required for the formation of the
epidermal barrier to water loss, and second, they are putative
regulators of keratinocyte growth and differentiation (Wakita et al,
1994; Marsh et al, 1995). Although sphingolipids in the epidermis
are limited to ®ve classes ± acylGlcCer, GlcCer, SM, acylCer and
Cer ± their structures and metabolism are not completely
understood.
In 1978, Gray and Yardley analyzed human epidermal GSLs and
detected three bands of GlcCers on TLC (Gray and Yardley, 1975).
In this study, we isolated four human epidermal GlcCer bands using
HPLC and identi®ed six molecular groups (summarized in
Table III). GlcCers are heterogeneous in their Cer components,
which are composed of combinations of at least six different
sphingosine bases (d18:1, d20:1, t18:0, t20:0, t18:1, and t20:1) and
13 amide-linked FAs (C16:0, C17:0, C18:0, C24:0, C25:0, C26:0,
C27:0, C28:0, C29:0, C30:0, C24 a h:0, C25 a h:0, and C26
a h:0). In addition to these GlcCers, we previously determined two
major molecular groups of human epidermal acylGlcCers,
epidermosides I and II. The former is de®ned by its dihydroxy-
sphingosine base, whereas the second is characterized by its
trihydroxysphingosine moiety. In epidermosides I and II, at least
Table II. Components of GlcCers
Carbohydrate Fr-1 Fr-2 Glucose Fr-3 Fr-4
Sphingosines d18:1, d20:1 d18:1, d20:1 d18:1, d20:1 d18:1
t18:0 t18:0, t20:0
t18:1, t20:1 t18:1, t20:1
Fatty acids (%)
16:0 7.2 5.0 3.1
17:0 6.9 4.8
18:0 11.6 7.8 4.5 4.2
24:0 16.3 3.9 12.7 3.6
25:0 5.4 5.3
26:0 22.0 9.4 23.3 3.7
27:0 3.9 3.9
28:0 19.0 11.4 15.3
29:0 4.5
30:0 5.1
24:0 (a-OH) 15.4 27.4
25:0 (a-OH) 8.1
26:0 (a-OH) 44.6 14.0 43.6
Others 2.8 8.6 0 9.4
Table I. Summary of 1H-NMR analysis of GlcCers
Peaks and chemical shift (ppm)/Coupling constants J (Hz)
Fr-1 Fr-2 Fr-3 Fr-4 Multiplicity Assigned structures
0.85/ 7.0 0.86/6.5 2 (-CH3) x 2
1.23-1.24 1 -(CH2) x-
4.09/ 7.70 4.11/ 7.70 4.08/ 7.70 4.14/ 7.70 m glucose (CH, 1-position)
2.94-3.00 2.93-3.00 2.92-2.99 2.90-3.00 m glucose (CH, 2-position)
3.03-3.22 3.01-3.18 3.03-3.16 3.03-3.12 m glucose (CH, 3, 4, 5-position)
3.47-3.53 3.46-3.53 3.43-3.50 3.62-3.70 m glucose (CH, 6-position)
3.64-3.69 3.64-3.69 3.64-3.69
7.37/ 9.00 7.39/ 9.80 7.39/ 9.40 7.49/ 9.40 d -NH-CO-(CH2)y-
7.48/ 9.00 and 7.47/9.00 and 7.50/ 8.60
7.61/ 9.00 7.49/ 9.50
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10 different w-OH FAs (C26 w h:0, C28 w h:0, C30 w h:0, C32
w h:0, C34 w h:0, C26 w h:1, C28 w h:1, C30 w h:1, C32 w h:1,
and C34 w h:1) represent the amide-linked FA component
(Hamanaka et al, 1989). This molecular heterogeneity of GlcCers
and acylGlcCers could be the source of the similarly diverse Cer
population (Cer 1±7) in the SC. To further investigate whether
epidermal GlcCers are indeed precursors of speci®c SC Cers, we
have taken a new approach to represent in vivo SC Cer production
from GlcCers. Isolated human epidermal GlcCers were hydrolyzed
by recombinant human b-GlcCer'ase in vitro and the resultant Cers
were compared with SC Cers. As summarized in Table III,
epidermal GlcCers contain Cer back-bone structures that are
equivalent to SC Cers, indicating that SC Cer 1±7 are generated
from GlcCers and acylGlcCers (Fig 6). In contrast to GlcCers,
epidermal SMs are composed of primary sphingenine (d18:1) and
10 molecules of amide-linked FAs (C16:0, C17:0, C18:0, C20:0,
C24:0, C24:1, C25:0, C26:0, C16 a h:0, and C18 a h:0), resulting
in the generation of Cer 2 and Cer 5. The proportion of Cer 2 and
Cer 5 in the total SC Cers is 17.6% and 20.5%, respectively (Uchida
et al, 2000). Therefore, GlcCers must be responsible for producing
more than 61.9% of the total SC Cer population, as well as at least
®ve of the seven Cer subtypes. To support the importance of
GlcCer for SC Cer formation, Gaucher type 2 patients, who have a
b-GlcCer'ase de®ciency, have signi®cant epidermal permeability
barrier abnormalities, whereas Niemann±Pick patients, whose
acidic sphingomyelinase activities are decreased, have normal
barrier function at basal conditions (Holleran et al, 1994;
Schmuth et al, 2000). Moreover, transgenic mice that lack b-
GlcCer'ase activity accumulate GlcCers, decrease Cers in the
epidermis, and display abnormality of the epidermal permeability
barrier function (Holleran et al, 1994). b-GlcCer'ase-de®cient
transgenic mice demonstrate altering the SC Cer composition, i.e.,
acylCers, phytosphingosine containing Cer and C24/26 a-OH
amide-linked FA containing Cer and not changing C16 a-OH
amide-linked FA containing Cer, as well as decreasing bulk of the
SC Cer (Doering et al, 1999b; Uchida et al, 2000). These prior
studies and our study provide evidence of the physiologic relevance
Figure 3. Negative-ion fast atom bombardment mass spectra of
Fr-1, Fr-2, Fr-3, and Fr-4. (A)Fr-1, (B)Fr-2, (C)Fr-3, (D)Fr-4.
Pseudo-molecular ions are described in bold, fragment ions due to the
elimination of hexose in normal type, and adduct ions in italics.
Table III. Structures of Cer moieties of human epidermal
GlcCers
GSLs Ceramide moieties SC Cersa
Epidermoside I C30:0wh-C18:2/d20:1 Cer 1 (EOS)
C32:1wh-C18:2/d20:1
Epidermoside II C30:0wh-C18:2/t20:1 Cer 4 (EOH)
GlcCer-1 C24:0/d20:1 Cer 2 (NS)
C26:0/d18:1
GlcCer-2 C24:0/t18:0 Cer 3 (NP)
GlcCer-3 C26:0/t20:1 Cer Y?b
C28:0/t20:1
C28:0/t18:1
GlcCer-4 C24:0ah/d18:1 Cer 5 (AS)
C24:0ah/d20:1
C26:0ah/d18:1
C26:0ah/d20:1
GlcCer-5 C24:0ah/t18:0 Cer 6 (AP)
GlcCer-6 C24:0ah/t20:1 Cer 7 (AH)
C26:0ah/t18:1
C26:0ah/t20:1
aRobson et al, 1994; bVietzke et al, 1999.
Figure 4. Cers generated by b-GlcCer'ase treatment of epidermo-
sides. Lanes 2 and 4 contain epidermosides I and II, respectively,
indicated by arrows. Lanes 3 and 5 contain Cers obtained by b-GlcCer'ase
treatment of epidermoside I or II, respectively. Lane 6 contains Cers with
w-OH FAs obtained from acylCers in lane 5 by saponi®cation. Lane 1
contains standard nonhydroxy Cers, a-OH Cers, and GlcCers.
Lane 8 shows the spectrum of Cer species obtained from human SC. Lane
7 contains nonhydroxy Cers as a standard.
420 HAMANAKA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
of GlcCers as a precursor of SC Cer. The importance of
sphingomyelinase-dependent Cer production, however, has been
demonstrated in Niemann±Pick patients following acute barrier
disruption (Schmuth et al, 2000). The importance of sphingomye-
linase-mediated epidermal responses in barrier recovery is also
suggested in a murine model upon acute barrier disruption (Jensen
et al, 1999). Thus, recovery of barrier function following acute and
chronic insults, including skin diseases such as atopic dermatitis,
psoriasis, and ichthyosis, may require both GlcCer- and SM-
dependent pathways to compensate for the reduction in barrier
lipids. Finally, it has not yet been elucidated whether de novo
synthesized Cer is directly delivered to the SC. As described above,
Figure 5. Cers generated by b-GlcCer'ase
treatment of human epidermal GlcCers. Lanes
3, 4, 5, and 6 contain Cers obtained by b-
GlcCer'ase treatment of human GlcCer fractions:
Cers from Fr-1 in lane 3, Cers from Fr-2 in lane
4, Cers from Fr-3 in lane 5, and Cers from Fr-4
in lane 6. Lane 7 contains Cers from Fr-4 lipids
but smaller contents. The symbol X indicates
byproducts that derive from the enzyme solution
containing detergent and stabilizer(s), and triangles
indicate GlcCers that were not hydrolyzed. Lanes
2 and 9 contain standard nonhydroxy Cers, a-
OH Cers, and GlcCers. Lane 1 shows Cer species
obtained from human SC. Lane 8 contains
nonhydroxy Cers as a standard.
Figure 6. Summary of proposed synthetic pathway of SC Cers. Abbreviations: PC, phosphatidylcholine; DG, diacylglycerol; UDP, uridine
diphosphate.
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however, the conversion of GlcCer and SM to Cer is required for
forming a competent barrier as well as displaying a SC Cer
molecular heterogeneity. Therefore, free Cer in the stratum
granulosum could not play a main role for SC Cer generation.
Based on these ®ndings, the proposed synthetic pathway of the SC
Cer is summarized in Fig 6.
Our previous studies and this study have de®ned the structures of
acylGlcCers and GlcCers in normal human epidermis. Two
questions have been raised, however. First, although Cer produced
from epidermoside II by b-GlcCer'ase showed the same Rf value as
Cer 4 (Fig 4), it should be noted that the structures of Cer 4
(Robson et al, 1994) and the Cer portion of epidermoside II
(Hamanaka et al, 1989) are not entirely the same, i.e., the positions
of the hydroxy residues in the sphingosine bases of these two
sphingolipids are different (Cer 4 contains 6-hydroxysphingenine,
whereas epidermoside II has 4-hydroxysphingenine). Thus, the role
of epidermoside II as a precursor of Cer 4 is still in question.
Second, an SC Cer potentially derived from GlcCer 3 is not
reported in SC Cer (Robson et al, 1994). Interestingly, Vietzke et al
(1999) found Cer X (N-acylsphinganine, C24-33:0/C18:0) and
Cer Y (N-acyl-6-OH-sphingosine, C22-32/t18:1) in human SC.
Although it is not determined whether the sphingosine base
structure of GlcCer 3 is 6-OH sphingosine, GlcCer 3 appears to be
a potential precursor of Cer Y.
Although pig and fetal rat contain both acylGlcCers and their
nonesteri®ed form, w-OH GlcCers, in the epidermis (Wertz and
Downing, 1983b; Wertz et al, 1984; Hamanaka et al, 1988),
humans only express acylGlcCers. Wertz et al proposed that fetal rat
epidermal w-OH GlcCers may be produced by the deacylation of
acylGlcCers (Wertz et al, 1984). If this were the case in humans, the
absence of w-OH GlcCers suggests that the human epidermis is
able to protect acylGlcCers from deacylation. The physiologic
meaning of this difference between human and other mammalian
epidermis GlcCers is unknown. The absence of w-OH GlcCers in
human epidermis, however, raises hypotheses regarding the
synthetic pathway of acylGlcCers and CLE formation. On the
synthesis of acylGlcCer, two pathways are postulated. First,
the synthesized w-OH Cers may be immediately acylated (addition
of linoleic acid) to acylCers followed by glucosylation to
acylGlcCers. Second, the w-OH FAs could be esteri®ed by linoleic
acid and then incorporated into sphingosine bases followed by
glucosylation. On the generation of the major lipid component in
the CLE, previous studies demonstrated that glucosylated w-OH
Cers ®rst covalently bind to the envelope proteins and then are
hydrolyzed by b-GlcCer'ase, based on Gaucher model transgenic
mice, which are de®cient in b-GlcCer'ase, and prosaposin
(sphingolipid activator proteins that stimulate enzymatic hydrolysis
of sphingolipids) de®cient transgenic mice (Doering et al, 1999a;
1999b).2 Supporting these results, immunohistochemistry using
anti-GlcCer antibody revealed that GlcCer is present at the
corni®ed envelopes of the cells only in the ®rst layer of the SC and
disappears in the upper SC (Vielhaber et al, 2001). Doering et al
proposed that acylGlcCers are the precursors of binding w-OH
Cers, by releasing linoleic acid and binding to proteins (Doering
et al, 1999b) (Fig 6). Our results, indicating the absence of free w-
OH GlcCer in epidermis, support the hypothesis that acylGlcCer
but not free w-OH GlcCer is a precursor of CLE-Cer. A recent
study indicated that w-OH Cers in the CLE are decreased in a rat
de®cient in essential fatty acids (Meguro et al, 2000), suggesting that
the linoleate moiety of acylGlcCers may play a critical role in
forming CLE structures. The enzyme transglutaminase is known to
form isopeptide bonds. Steinert and coworkers discovered a novel
function of transglutaminase, i.e., transglutaminase 1, but not
transglutaminase 2 and 3, forms the ester linkage between
involucrin and a synthetic pseudo-w-OH Cer, 16-(16hydroxy-
hexadecyl)oxypalmitoyl sphingenine, which displays similar
solubility and chromatographic properties to natural w-OH Cers
(Nemes et al, 1999). They hypothesized that the thioester bond
between transglutaminase 1 and a Gln residue of involucrin is
replaced by the w-OH group of w-OH Cers, forming a Glu-O-
Cer linkage. Based on this hypothesis, acylGlcCers may be
hydrolyzed to w-OH GlcCer followed by a nucleophilic w-OH
attack on the thioester bond. As Doering et al (1999b) suggested, it
is also possible that transesteri®cation occurs between acylGlcCers
and the carboxy group of CE proteins, resulting in the formation of
CE-w-O-Cers and the subsequent release of linoleic acid, mediated
by an as-yet unknown enzyme(s) or by nonenzymatic reaction.
In addition to w-OH GlcCers, it is known that the sphingosine
base and ester-linked FA of acylGlcCers are different between the
epidermis of humans and other mammals. We reported that there
are two types of human acylGlcCers characterized by their unique
sphingosine bases, sphingenine and phytosphingosine with one
double bond. Animal epidermis contains only one acylGlcCer
group with sphingenine, however. Furthermore, linoleic acid is the
ester-linked FA in 95% of human epidermal acylGlcCers
(Hamanaka et al, 1989), but this ®gure is only 75%±77% in pig
(Gray et al, 1978; Wertz and Downing, 1983a), 32% in rat (Wertz
et al, 1984), 45% in mouse (Wertz and Downing, 1985), and 84% in
guinea pig (Uchida et al, 1988). As linoleic acid is essential in
epidermal barrier function (Elias et al, 1980; Hansen, 1986),
acylGlcCers carrying linoleic acid must play a key role in forming
this barrier. In this respect, human epidermis may possess a selective
mechanism for the production of functional acylGlcCers. These
linoleic-acid-carrying acylGlcCers were named epidermosides to
stress their role in barrier function (Hamanaka et al, 2001).
Moreover, epidermosides may be important in the formation of the
CLE, as described above.
Alterations of the content and composition of SC Cers in atopic
dermatitis patients have been reported by several investigators
(Melnik et al, 1988; Imokawa et al, 1991; Yamamoto et al, 1991; Di
Nardo et al, 1998; Bleck et al, 1999). In particular, Cer 1 is
markedly decreased in skin from such patients. Their b-GlcCer'ase
and sphingomyelinase activity were normal, however (Jin et al,
1994), and no accumulation of GlcCers and SM were reported in
their SC. Imokawa and coworkers found that glucosylceramide
sphingomyelin deacylase (or sphingomyelin deacylase) but not
sphingomyelinase or ceramidase activity was increased in atopic
dermatitis lesions (Hara et al, 2000; Higuchi et al, 2000). They
proposed that the reduction in SC Cers is due to increased
glucosylceramide sphingomyelin deacylase activity. The structural
preferences of glucosylceramide sphingomyelin deacylase have not
been de®ned, however, to explain why acylGlcCer-derived, but
not SM-derived, Cer 1 is speci®cally decreased. Interestingly, Bleck
et al (1999) reported that short chain a-OH acyl (C16 and C18)
sphingenine or hydroxysphingenine is increased in unaffected skin
of atopic dermatitis patients, whereas normal control subjects
contain long chain a-OH acyl (C22 to C26) sphingenine or
hydroxysphingenine. Our previous results (Uchida et al, 2000) and
these results suggest that Cer containing short chain a-OH FAs
(primarily C16) with sphingenine derives from SMs (SM-2),
whereas Cer with long chain a-OH FAs is derived from GlcCers.
Thus, alterations in GlcCer or SM synthesis as well as increasing
glucosylceramide sphingomyelin deacylase activity may occur in
atopic dermatitis. A recent study revealed that increases in Cer 2
and Cer 5 are evident in the human SC with dry skin symptom,
whereas Cer 4 decreases (Schreiner et al, 2000). Changes in Cer
proportion derived from GlcCer and SM may often occur in this
skin type; however, the mechanism responsible for the metabolic
changes has not yet been de®ned.
Our previous studies (Uchida et al, 2000) and this study of
epidermal SM and GlcCer structures further de®ne the synthetic
pathway for SC Cer formation. These results not only elucidate the
metabolic source for speci®c epidermal Cer species, but also help to
de®ne potential metabolic steps that are modi®ed in/by skin
disease(s).
2Uchida Y et al: Formation of the lipid-bound envelope (LBE): insights
from glucocerebrosidase-de®cient Gaucher mouse epidermis. J Invest
Dermatol 112:543, 1999 (abstr.)
422 HAMANAKA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
The authors wish to thank Drs Tohru 1noue and Hisato Higashi (Tokyo Kosei-
Nenkin Hospital, Tokyo, Japan) for their donations of human skin tissue and Drs
Peter M. Elias and Walter M. Holleran (Department of Dermatology, Veterans
Administration Medical Center and University of California, San Francisco, CA,
U.S.A.) for numerous helpful discussions.
REFERENCES
Abraham W, Wertz PW, Downing DT: Linoleate-rich acylglucosylceramides of pig
epidermis: determination by proton magnetic resonance. J Lipid Res 26:761±
765, 1985
Ando S, Yu RK: Isolation and characterization of two isomers of brain
tetrasialogangliosides. J Biol Chem 254:12224±12229, 1979
Bleck O, Abeck D, Ring J, et al: Two ceramide subfractions detectable in Cer (AS)
position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema.
J Invest Dermatol 113:894±900, 1999
Bouwstra JA, Gooris GS, Dubbelaar FE, Weerheim AM, Ijzerman AP, Ponec M:
Role of ceramide 1 in the molecular organization of the stratum corneum
lipids. J Lipid Res 39:186±196, 1998
Bowser PA, Nugteren PH, White RJ, Houtsmuller UMT, Protty C: Identi®cation,
isolation and characterization of epidermal lipids containing linoleic acid.
Biochim Biophys Acta 834:419±428, 1985
Chujor CS, Feingold KR, Elias PM, Holleran WM: Glucosylceramide synthase
activity in murine epidermis: quantitation, localization, regulation, and
requirement for barrier homeostasis. J Lipid Res 39:277±285, 1998
Di Nardo A, Wertz P, Giannetti A, Seidenari S: Ceramide and cholesterol
composition of the skin of patients with atopic dermatitis. Acta Derm Venereol
78:27±30, 1998
Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K:
Sphingolipid activator proteins are required for epidermal permeability barrier
formation. J Biol Chem 274:11038±11045, 1999a
Doering T, Proia RL, Sandhoff K: Accumulation of protein-bound epidermal
glucosylceramides in beta-glucocerebrosidase de®cient type 2 Gaucher mice.
FEBS Lett 447:167±170, 1999b
Downing DT: Lipid and protein structures in the permeability barrier of mammalian
epidermis. J Lipid Res 33:301±313, 1992
Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal
permeability barrier. Adv Lipid Res 24:1±26, 1991
Elias PM, Brown BE, Ziboh VA: The permeability barrier in essential fatty acid
de®ciency: evidence for a direct role for linoleic acid in barrier function. J Invest
Dermatol 74:230±233, 1980
Elias PM, Fartasch M, Crumrine D, Behne M, Uchida Y, Holleran WM: Origin of
the corneocyte lipid envelope (CLE): observations in Harlequin ichthyosis and
cultured human keratinocytes. J Invest Dermatol 115:765±769, 2000
Folch AJ, Lees M, Stanley GH: A simple method for the isolation and puri®cation of.
total lipids from animal tissues. J Biol Chem 226:497±509, 1957
Gray GM, White RJ: Glycosphingolipids and ceramides in human and pig epidermis.
J Invest Dermatol 70:336±341, 1978
Gray GM, Yardley HJ: Different populations of pig epidermal cells: isolation and lipid
composition. J Lipid Res 16:441±447, 1975
Gray GM, White RJ, Major JR: 1-(3¢-O-acyl) -b-glucosyl-N-dihydroxy-pentatri-
acontadienoyl-sphingosine, a major component of the glucosylceramides of pig
and human epidermis. Biochim Biophys Acta 528:127±137, 1978
Hamanaka S, Yamaguchi Y, Yamamoto T, Asagami C: Occurrence of
galactosylceramide in pig epidermal cells. Biochim Biophys Acta 961:374±377,
1988
Hamanaka S, Asagami C, Suzuki M, Ingaki F, Suzuki A: Structure determination of
glucosyl beta-1-N-(w-O-linoleoyl)-acylsphingosines of human epidermis. J
Biochem 105:684±490, 1989
Hamanaka S, Asagami C, Kobayashi K, Ishibashi Y, Otsuka F: Sphingoglycolipids in
human cultured keratinocytes. Arch Dermatol Res 282:345±347, 1990
Hamanaka S, Takemoto T, Hamanaka Y, Asagami C, Suzuki M, Suzuki A, Otsuka
F: Structure determination of glycosphingolipids of cultured human
keratinocytes. Biochim Biophys Acta 1167:1±8, 1993
Hamanaka S, Suzuki M, Suzuki A, Yamakawa T: Epidermosides: structure and
function of skin-speci®c glycolipids. Proc Jpn Acad 77(B):51±56, 2001
Hansen HS: The essential nature of linoleic acid in mammals. Trends Biochem Sci
11:263±265, 1986
Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High expression of
sphingomyelin deacylase is an important determinant of ceramide de®ciency
leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115:406±413,
2000
Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G: The skin of atopic
dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin
deacylase, which cleaves the N-acyl linkage of sphingomyelin and
glucosylceramide. Biochem J 350 Pt 3:747±756, 2000
Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing
of epidermal glucosylceramides is required for optimal mammalian cutaneous
permeability barrier function. J Clin Invest 91:1656±1664, 1993
Holleran WM, Ginns EI, Menon GK, et al: Consequences of beta-glucocerebrosidase
de®ciency in epidermis. Ultrastructure and permeability barrier alterations in
Gaucher disease. J Clin Invest 93:1756±1764, 1994
Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of
ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic
dry skin? J Invest Dermatol 96:523±526, 1991
Jensen JM, SchuÈtze S, FoÈrl M, KroÈnke M, Proksch E: Roles for tumor necrosis factor
receptor p55 and sphingomyelinase in repairing the cutaneous permeability
barrier. J Clin Invest 104:1761±1770, 1999
Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G: Analysis
of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin.
Acta Derm Venereol 74:337±340, 1994
Karlsson KA, Martensson E: Studies on sphingosines. XIV. On the phytosphingosine
content of the major human kidney glycolipids. Biochim Biophys Acta 152:230±
233, 1968
Marekov LN, Steinert PM: Ceramides are bound to structural proteins of the human
foreskin epidermal corni®ed cell envelope. J Biol Chem 273:17763±17770,
1998
Marsh NL, Elias PM, Holleran WM: Glucosylceramides stimulate murine epidermal
hyperproliferation. J Clin Invest 95:2903±2909, 1995
Meguro S, Arai Y, Masukawa Y, Uie K, Tokimitsu I: Relationship between
covalently bound ceramides and transepidermal water loss (TEWL). Arch
Dermatol Res 292:463±468, 2000
Melnik B, Hollmann J, Plewig G: Decreased stratum corneum ceramides in atopic
individuals a pathobiochemical factor in xerosis? Br J Dermatol 119:547±549,
1988
Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide
composition of the psoriatic scale. Biochim Biophys Acta 1182:147±151, 1993
Nemes Z, Marekov LN, Fesus L, Steinert PM: A novel function for transglutaminase
1: attachment of long-chain w-hydroxyceramides to involucrin by ester bond
formation. Proc Natl Acad Sci USA 96:8402±8407, 1999
Paige DG, Morse-Fisher N, Harper JI: Quanti®cation of stratum corneum ceramides
and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol
131:23±27, 1994
Ponec M, Weerheim A: Retinoids and lipid changes in keratinocytes. Methods
Enzymol 190:30±41, 1990
Ponec M, Weerheim A, Kempenaar J, Mommaas AM, Nugteren DH: Lipid
composition of cultured human keratinocytes in relation to their
differentiation. J Lipid Res 29:949±961, 1988
Robson KJ, Stewart ME, Michelsen S, Lazo ND, Downing DT: 6-Hydroxy-4-
sphingeninde in human epidermal ceramides. J Lipid Res 35:2060±2068, 1994
Sando GN, Howard EJ, Madison KC: Induction of ceramide glucosyltransferase
activity in cultured human keratinocytes. Correlation with culture
differentiation. J Biol Chem 271:22044±22051, 1996
Schmuth M, Man MQ, Weber F, et al: Permeability barrier disorder in Niemann±
Pick disease: sphingomyelin-ceramide processing required for normal barrier
homeostasis. J Invest Dermatol 115:459±466, 2000
Schreiner V, Gooris GS, Pfeiffer S, et al: Barrier characteristics of different human
skin types investigated with X-ray diffraction, lipid analysis, and electron
microscopy imaging. J Invest Dermatol 114:654±660, 2000
Uchida Y, Iwamori M, Nagai Y: Distinct differences in lipid composition between
epidermis and dermis from footpad and dorsal skin of guinea pigs. Jpn J Exp
Med 58:153±161, 1988
Uchida Y, Hara M, Nishio H, et al: Epidermal sphingomyelins are precursors for
selected stratum corneum ceramides. J Lipid Res 41:2071±2082, 2000
Vielhaber G, Pfeiffer S, Brade L, et al: Localization of ceramide and glucosylceramide
in human epidermis by immunogold electron microscopy. J Invest Dermatol
117:1126±1136, 2001
Vietzke J-P, Strassner M, Hintze U: Separation and identi®cation of ceramides in the
human stratum corneum by high-performance liquid chromatography coupled
with electrospray ionization mass spectrometry and electrospray multiple-stage
spectrometry proli®ng. Chromatographica 50:15±20, 1999
Vietzke J-P, Brandt O, Abeck D, Rapp C, Strassner M, Schreiner V, Hintze U:
Comparative investigation of human stratum corneum ceramides. Lipids
36:299±304, 2001
Wakita H, Tokura Y, Yagi H, Nishimura K, Furukawa F, Takigawa M: Keratinocyte
differentiation is induced by cell-permeant ceramides and its proliferation is
promoted by sphingosine. Arch Dermatol Res 286:350±354, 1994
Watanabe R, Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR, Pagano RE:
Up-regulation of glucosylceramide synthase expression and activity during
human keratinocyte differentiation. J Biol Chem 273:9651±9655, 1998
Wertz PW, Downing DT: Glycolipids in mammalian epidermis: structure and
function in the water barrier. Science 217:1261±1262, 1982
Wertz PW, Downing DT: Acylglucosylceramides of pig epidermis: structure
determination. J Lipid Res 24:753±758, 1983a
Wertz PW, Downing DT: Glucosylceramides of pig epidermis: structure
determination. J Lipid Res 24:1135±1139, 1983b
Wertz PW, Downing DT: Ceramides of pig epidermis: structure determination. J
Lipid Res 24:759±765, 1983c
Wertz PW, Downing DT: Linoleate content of epidermal acylglucosylceramide in
newborn, growing and mature mice. Biochim Biophys Acta 876:469±473, 1985
Wertz PW, Downing DT: Covalently bound w-hydroxyacylsphingosine in the
stratum corneum. Biochim Biophys Acta 917:108±111, 1987
Wertz PW, Downing DT, Freinkel RK, Traczyk TN: Sphingolipids of the stratum
corneum and lamellar granules of fetal rat epidermis. J Invest Dermatol 83:193±
195, 1984
Wertz PW, Madison KC, Downing DT: Covalently bound lipids of human stratum
corneum. J Invest Dermatol 92:109±111, 1989
Yamamoto A, Serizawa S, Ito M, Sato Y: Stratum corneum lipid abnormalities in
atopic dermatitis. Arch Dermatol Res 283:219±223, 1991
VOL. 119, NO. 2 AUGUST 2002 GLUCOSYLCERAMIDES IN HUMAN EPIDERMIS 423
